Anne-Margaret Botelho
Psychiatric/Mental Health · Mattapoisett, MANPI 1902440977
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (43.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Axsome Therapeutics, Inc. accounts for 88.7% of it on its own, with 24 other manufacturers making up the rest. Among psychiatric/mental health clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 309 payments — averaging $150.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$41K
- Otsuka America Pharmaceutical, Inc.$975
- AbbVie$797
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$627
- Lundbeck LLC$567
- Alkermes, Inc.$386
- plus $2K from 19 others
What the payments were for
- Consulting fees$20,06343%
- Speaking & faculty fees$7,43816%
- Travel & lodging$10,48423%
- Food & beverage$8,47418%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axsome Therapeutics, Inc. | 96 | $41,198 |
| Otsuka America Pharmaceutical, Inc. | 32 | $975 |
| AbbVie | 35 | $797 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 19 | $627 |
| Lundbeck LLC | 35 | $567 |
| Alkermes, Inc. | 13 | $386 |
| Johnson & Johnson | 7 | $323 |
| Corium, LLC | 14 | $248 |
| E.r. Squibb & Sons, L.L.C. | 2 | $149 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $147 |
| Sunovion Pharmaceuticals Inc. | 10 | $145 |
| Supernus Pharmaceuticals, Inc. | 7 | $128 |
| Neurocrine Biosciences, Inc. | 6 | $120 |
| Novo Nordisk | 5 | $117 |
| Biogen | 1 | $116 |
| Collegium Pharmaceutical, Inc. | 4 | $84 |
| Vanda Pharmaceuticals Inc. | 3 | $70 |
| Sage Therapeutics, LLC | 3 | $70 |
| Tempus AI, Inc | 2 | $50 |
| Lilly USA, LLC | 2 | $43 |
| Indivior Inc. | 1 | $27 |
| Vertical Pharmaceuticals, LLC | 1 | $19 |
| Tris Pharma Inc | 1 | $19 |
| Cosette Pharmaceuticals Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auvelity$39,542
- LYBALVI$480
- ARISTADA$400
- REXULTI$248
- CAPLYTA$245
- SPRAVATO$127
- ABILIFY MAINTENA$125
- ABILIFY ASIMTUFII$125
- COBENFY$123
- Zurzuvae$116
- ARISTADA INITIO$100
- VRAYLAR$100
How this compares
$46,458 in reported general payments places this provider in the 95th percentile of 1,284 psychiatric/mental health providers in Massachusetts.
See all psychiatric/mental health providers in Massachusetts →
Other psychiatric/mental health in Mattapoisett
- Brianne LienkampMarion$121K
- Ashley BakerQuincy$54K
- Brian BanksPembroke$47K
- Matthew PeculisWalpole$41K
- Sherrie UrenaWorcester$21K
- Irina DauphineeHanover$18K
- Schree PettigrewNew Bedford$18K
- Sherryl RosenLynn$16K
- Kevin NardoneWorcester$16K
- Edward TiminskiWorcester$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.